U.S. researchers used umbilical cord stem cells to "re-educate" the T-cells of type 1 diabetes patients, allowing the renewal of insulin production by the pancreas and reducing the need for injected insulin by up to 38% in 12 weeks. The results of the 15-person study were published in the journal BMC Medicine.

Related Summaries